[The therapeutic use of anti-A-HP in the treatment of staphylococcal skin diseases as a result of the affinity of the heterophil anti-A-HP AGGLUTININS FOR TEICHOIC ACID].
D000017:ABO Blood-Group System; D000143:Acids / Q000096:biosynthesis; D000906:Antibodies; D006801:Humans; D010756:Phosphoric Acids; D011108:Polymers; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000378:metabolism
D000017:ABO Blood-Group System; D000143:Acids; D000906:Antibodies; D010756:Phosphoric Acids; D011108:Polymers
Die therapeutische Verwendung von Anti-A-HP zur Behandlung staphylogener Hauterkrankungen infolge der Affinität des heterophilen Anti-A-HP-Agglutinins zur Teichonsäure.